This indicates that, in many cases, deregulation of E-cadherin mobility rather than expression level may play an additional role in promoting invasion and suggests that monitoring E-cadherin behavior in this context could lead to a greater understanding of cancer invasion and response to new therapeutics (Wicki et al., 2006). This evidence concerns the gene CDH1 and cancer.